Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	41.25	36.6	50.31	24.94	25.34
Short-Term Investments	-	698.44	458.25	415.55	495.14	520.18
Cash & Short-Term Investments	776.86	739.69	494.84	465.86	520.07	545.52
Cash Growth	39.50%	49.48%	6.22%	-10.42%	-4.67%	4.26%
Accounts Receivable	-	194.75	169.62	152.07	140.01	178.3
Other Receivables	-	50.02	42.28	21.31	43.02	42.32
Receivables	-	245.67	213.08	175.28	184.14	222.8
Inventory	-	85.66	83.38	98.98	76.17	109.15
Prepaid Expenses	-	7.09	4.59	5.53	4.36	4.82
Other Current Assets	-	19.17	15.02	13.39	15.13	13.14
Total Current Assets	-	1,097	810.91	759.04	799.87	895.43
Property, Plant & Equipment	-	112.14	112.19	113.05	104.47	110.03
Long-Term Investments	-	173.9	344.09	415.71	209.79	24.97
Goodwill	-	-	-	-	0.01	0.01
Other Intangible Assets	-	3.88	1.87	3.06	4.8	8.41
Long-Term Deferred Tax Assets	-	7.98	4.25	3.71	7.37	-
Other Long-Term Assets	-	255.51	144.23	133.59	84.71	3.53
Total Assets	-	1,651	1,418	1,429	1,212	1,043
Accounts Payable	-	62.57	60.97	71.1	45.92	52.26
Accrued Expenses	-	9.31	2.55	2.59	12.73	21.73
Short-Term Debt	-	-	24.39	58.15	37.11	34.39
Current Portion of Leases	-	-	4.89	4.51	4.17	3.85
Current Income Taxes Payable	-	16.41	3.37	0.77	2	4.41
Other Current Liabilities	-	75.49	61.46	75.67	78	81.37
Total Current Liabilities	-	163.79	157.62	212.8	179.92	198.01
Long-Term Leases	-	-	-	4.89	9.4	13.56
Long-Term Deferred Tax Liabilities	-	7.9	7.18	8.56	8.21	2.38
Other Long-Term Liabilities	-	29.91	29.43	29.43	29.65	29.08
Total Liabilities	-	201.59	194.22	255.67	227.17	243.04
Common Stock	-	44.13	44.13	45.89	45.89	45.89
Retained Earnings	-	1,375	1,165	1,119	942.57	777.55
Comprehensive Income & Other	-	30.62	15.25	9.2	-3.8	-23.4
Shareholders' Equity	1,578	1,449	1,224	1,174	984.66	800.04
Total Liabilities & Equity	-	1,651	1,418	1,429	1,212	1,043
Total Debt	21.14	-	29.28	67.55	50.67	51.8
Net Cash (Debt)	755.72	739.69	465.57	398.31	469.4	493.72
Net Cash Growth	36.35%	58.88%	16.89%	-15.15%	-4.92%	10.07%
Net Cash Per Share	171.24	167.61	101.97	86.79	102.28	107.58
Filing Date Shares Outstanding	4.41	4.41	4.41	4.59	4.59	4.59
Total Common Shares Outstanding	4.41	4.41	4.41	4.59	4.59	4.59
Working Capital	-	933.49	653.29	546.24	619.95	697.42
Book Value Per Share	357.41	328.42	277.32	255.77	214.55	174.32
Tangible Book Value	1,575	1,446	1,222	1,171	979.85	791.62
Tangible Book Value Per Share	356.75	327.54	276.90	255.10	213.50	172.49
Buildings	-	107.24	103.86	101.39	96.73	96.23
Machinery	-	206.45	193.64	191.2	178.46	172.71
Construction In Progress	-	12.41	9.57	2.12	3.78	1.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.